Published in Immunology on April 01, 1970
Studies on natural antibodies to gram-negative bacteria. J Exp Med (1962) 4.25
Developmental aspects of immunity. Adv Immunol (1967) 3.35
Sensitivity of rough gram-negative bacteria to the bactericidal action of serum. J Bacteriol (1968) 2.68
THE NATURE OF THE OPSONINS IN ADULT HEN SERUM AND DEVELOPING CHICK EMBRYOS TO CERTAIN GRAM-NEGATIVE BACTERIA. Aust J Exp Biol Med Sci (1964) 1.27
The functional development of the reticulo-endothelial system. 3. The bactericidal capacity of fixed macrophages of foetal and neonatal chicks and rats. Immunology (1965) 1.16
The origin of the antibody released into serum following injection of bacterial lipopolysaccharide. Aust J Exp Biol Med Sci (1967) 1.04
Immunity to Salmonella gallinarum during ontogeny of the chicken. 3. Bactericidal antibody. Immunology (1968) 0.94
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry (1978) 22.56
Mortality among infants of black as compared with white college-educated parents. N Engl J Med (1992) 5.65
The role of the flagellum in the adherence of Vibrio cholerae. J Infect Dis (1983) 3.91
Intestinal colonization and virulence of Salmonella in mice. Infect Immun (1978) 3.44
A simple index to predict prognosis independent of axillary node information in breast cancer. Aust N Z J Surg (1997) 2.71
Sensitivity of rough gram-negative bacteria to the bactericidal action of serum. J Bacteriol (1968) 2.68
Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development. Infect Immun (1986) 2.36
Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group. J Clin Oncol (1993) 2.15
The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement. J Infect Dis (1970) 2.03
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Experimental cholera in infant mice: protective effects of antibody. J Infect Dis (1972) 1.81
Be wary of subsidising nicotine replacement therapy. Tob Control (2002) 1.67
Number of molecules of antibody required to promote phagocytosis of one bacterium. Nature (1966) 1.65
Further studies regarding the question of cellular immunity in mouse typhoid. Aust J Exp Biol Med Sci (1968) 1.65
Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci (Lond) (1984) 1.61
Antibody cross-linking as a factor in immunity to cholera in infant mice. J Infect Dis (1975) 1.61
Isotypes of mouse IgG--I. Evidence for 'non-complement-fixing' IgG1 antibodies and characterization of their capacity to interfere with IgG2 sensitization of target red blood cells for lysis by complement. Mol Immunol (1980) 1.59
Development of a rating system for surgeons' non-technical skills. Med Educ (2006) 1.59
Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol (1995) 1.58
In vitro dorsal root ganglia and human prostate cell line interaction: redefining perineural invasion in prostate cancer. Prostate (2001) 1.58
Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a. Infect Immun (1990) 1.55
Endotoxins and bacterial virulence. J Infect Dis (1971) 1.51
The colonization of Peyer's patches by a strain of Salmonella typhimurium cured of the cryptic plasmid. J Infect Dis (1986) 1.49
Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. I. Measurement of serum antibodies by radioimmunoassay. Clin Exp Immunol (1981) 1.49
Antibacterial mechanisms in the intestine. Elimination of V. cholerae from the intestines of infant mice and the role of antibody. Aust J Exp Biol Med Sci (1975) 1.46
The antibody response to bacterial gastroenteritis in serum and secretions. Clin Exp Immunol (1980) 1.43
Delayed antigen presentation by epidermal Langerhans cells to cloned T h1 and T h2 cells. J Invest Dermatol (1990) 1.41
Sensitization of complement resistant bacterial strains. Nature (1969) 1.40
Phagocytosis and immunity. The carrier state and cellular immunity. Experientia (1966) 1.36
Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function. Mol Endocrinol (2001) 1.35
Complement-fixing IgG1 constitutes a new subclass of mouse IgG. Nature (1979) 1.34
Preparation of an artificial antigen and immunity to mouse typhoid. Immunology (1967) 1.33
Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. Clin Cancer Res (1998) 1.33
Isolation and biological properties of three classes of rabbit antibody to Vibrio cholerae. J Infect Dis (1974) 1.33
Opsonic requirements for bacterial phagocytosis. Nature (1965) 1.31
A simple index using video image analysis to predict disease outcome in primary breast cancer. Int J Cancer (1999) 1.31
Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. Cancer Res (1994) 1.31
Passive sensitization of Salmonella adelaide to the bactericidal action of antibody and complement. Nature (1968) 1.29
Antibacterial action of specific IgA and transport of IgM, IgA, and IgG from serum into the small intestine. J Infect Dis (1971) 1.27
Antibacterial mechanisms in the intestine. Elimination of V. cholerae from the gastrointestinal tract of adult mice. Aust J Exp Biol Med Sci (1975) 1.24
Teaching surgeons about non-technical skills. Surgeon (2007) 1.23
Cerebral and ocular toxicity induced by desferrioxamine. Q J Med (1985) 1.21
Protection against cholera. A bactericidal mechanism on the mucosal surface of the small intestine of mice. Aust J Exp Biol Med Sci (1975) 1.20
The relative antibacterial efficiency of IgM, IgG and IgA from pig colostrum. Aust J Exp Biol Med Sci (1971) 1.17
Intestinal and serum antibody responses in mice after oral immunization with Salmonella, Escherichia coli, and Salmonella-Escherichia coli hybrid strains. Infect Immun (1979) 1.17
Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study. Br J Cancer (1989) 1.17
The functional development of the reticulo-endothelial system. 3. The bactericidal capacity of fixed macrophages of foetal and neonatal chicks and rats. Immunology (1965) 1.16
Prophylactic significance of the nonlipopolysaccharide antigens of Vibrio cholerae. J Infect Dis (1983) 1.15
Decreasing trends in Reye syndrome and aspirin use in Michigan, 1979 to 1984. Pediatrics (1986) 1.15
Hospitalizations for severe complications of pregnancy, 1987-1992. Obstet Gynecol (1997) 1.14
The synthesis of macroglobulin antibody to a bacterial antigen in mice after treatment with thorotrast. Aust J Exp Biol Med Sci (1965) 1.13
Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells. Mol Cell Endocrinol (1999) 1.12
Dog immunoglobulins. I. immunochemical characterization of dog serum, parotid saliva, colostrum, milk and small bowel fluid. Immunology (1975) 1.12
Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1. Cancer Res (2001) 1.11
Maternal and perinatal mortality. Curr Opin Obstet Gynecol (1992) 1.11
Phagocytosis and immunity. The central role of phagocytosis in immune reactions. Experientia (1966) 1.10
Further evidence for cross-linking as a protective factor in experimental cholera: properties of antibody fragments. J Infect Dis (1975) 1.10
Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. II. Measurement of intestinal antibodies by radioimmunoassay. Clin Exp Immunol (1981) 1.09
EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene (1997) 1.08
Protection of infant mice against cholera by antibodies to three antigens of Vibrio cholerae. J Infect Dis (1972) 1.08
The significance of oncogene amplification in primary breast cancer. Int J Cancer (1989) 1.06
The functional heterogeneity of macrophages at the single cell level. Aust J Exp Biol Med Sci (1967) 1.05
Role of TGF-beta in immune-evasion of cancer. Microsc Res Tech (2001) 1.05
The origin of the antibody released into serum following injection of bacterial lipopolysaccharide. Aust J Exp Biol Med Sci (1967) 1.04
Dog immunoglobulins. II. The antibacterial properties of dog IgA, IgM and IgG antibodies to Vibrio cholerae. Immunology (1975) 1.02
Bacterial lipopolysaccharide-induced intestinal microvascular lesions leading to acute diarrhea. J Clin Invest (1988) 1.02
National trends in the incidence of abruptio placentae, 1979-1987. Obstet Gynecol (1991) 1.01
A quantitative comparison of the antigenic structure of a virulent and an avirulent strain of Salmonella typhimurium. Immunology (1969) 1.01
Re-examination of small intestinal disposal of Vibrio cholerae in mice. Aust J Exp Biol Med Sci (1977) 1.01
The effect of lysozyme on the complement-dependent bactericidal action of different antibody classes. Immunology (1975) 0.99
The development of resistance in different inbred strains of mice to infection with Nematospiroides dubius. Parasite Immunol (1979) 0.98
Phagocytosis of bacteria in vitro by haemocytes from the crayfish (Parachaeraps bicarinatus). Aust J Exp Biol Med Sci (1974) 0.97
The functional development of the reticulo-endothelial system. I. The uptake of intravenously injected particles by foetal rats. Immunology (1965) 0.97
Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Clin Cancer Res (1996) 0.97
Cognitive representations of illness and functional and affective adjustment following surgery for osteoarthritis. Soc Sci Med (1998) 0.96
Resistance to Klebsiella pneumoniae and the importance of two bacterial antigens. Aust J Exp Biol Med Sci (1982) 0.96
Oral immunization with live, avirulent fla+ strains of Salmonella protects mice against subsequent oral challenge with Salmonella typhimurium. J Infect Dis (1988) 0.96
The serum polymeric IgA antibody response to typhoid vaccination; its relationship to the intestinal IgA response. Immunology (1990) 0.96
Immunity in the invertebrates. I. Studies on the naturally occurring haemagglutinins in the fluid from invertebrates. Aust J Exp Biol Med Sci (1969) 0.95
Elevated stromal chondroitin sulfate glycosaminoglycan predicts progression in early-stage prostate cancer. Clin Cancer Res (1997) 0.95
Mechanism of inhibition of a poxvirus topoisomerase by the marine natural product sansalvamide A. Mol Pharmacol (1999) 0.94
Measurement of intestinal antibody by radioimmunoassay. Clin Exp Immunol (1980) 0.94
Postneonatal mortality surveillance--United States, 1980-1994. MMWR CDC Surveill Summ (1998) 0.94
Immunogenicity of a candidate live oral typhoid/cholera hybrid vaccine in humans. J Infect Dis (1989) 0.94
Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis. Int J Cancer (1996) 0.94
Antibodies in serum and secretions 1 year after salmonella gastroenteritis. Clin Exp Immunol (1982) 0.93
Evidence implicating the mononuclear phagocytic system of the rat in immunity to infections with Trypanosoma lewisi. Aust J Exp Biol Med Sci (1978) 0.93
Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer. Br J Cancer (1986) 0.93
Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer. Br J Cancer (1996) 0.93
Immunity in the invertebrates. Correlation of the phagocytic activity of haemocytes with resistance to infection in the crayfish (Parachaeraps bicarinatus). Aust J Exp Biol Med Sci (1970) 0.92
Self-efficacy and goal importance in the prediction of physical disability in people following hospitalization: a prospective study. Br J Health Psychol (2001) 0.92
Surface immunoglobulins, a possible mechanism for the persistence of Trypanosoma lewisi in the circulation of rats. Aust J Exp Biol Med Sci (1977) 0.92
Medroxyprogesterone acetate therapy in advanced breast cancer: the predictive value of androgen receptor expression. J Clin Oncol (1995) 0.92
Vimentin expression is not associated with poor prognosis in breast cancer. Int J Cancer (1996) 0.91
Mechanisms of antibacterial immunity against Vibrio cholerae in the intestinal tracts of baby mice. J Infect Dis (1973) 0.91
Selected antepartum medical complications and very-low-birthweight infants among black and white women. Am J Public Health (1994) 0.90